English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Astrazeneca International
Robert Hadley
| Jun 21, 2017
Clinical trial deems AstraZeneca’s Lynparza better for mutation-caused breast cancer than chemotherapy
Amanda Rupp
| Mar 23, 2016
AstraZeneca releases results of Brilinta stroke trial
Trending
+
Technology/Innovation
Patient Daily News Service
| Oct 9, 2025
Babylon Health collapse raises questions about AI claims across industries
Patient Daily
| Oct 9, 2025
Medfluence Advisors Marketing Expert: 'The conversations leading into AAO-HNSF are shaping how ENT practices approach growth and engagement'
+
Pharmaceuticals
Patient Daily
| Oct 8, 2025
American Lung Association launches campaign urging vaccinations against seasonal flu and respiratory illnesses
Patient Daily
| Oct 6, 2025
Drug Channels Institute president: ‘A growing share of 340B dollars are captured by for-profit pharmacies and PBMs’
